Global Biosimilars Market Is Estimated to Grow at a CAGR of +6% by 2025 Top Companies are Pfizer, Sandoz, Teva Pharmaceuticals, Amgen, Biocon, Dr. Reddy’s Laboratories, Celltrion


PUNE, India, July 05, 2019 (GLOBE NEWSWIRE) -- Global Biosimilars Industry was valued at USD $7.75 Billion in the year 2019. Global Biosimilars Industry is further estimated to grow at a CAGR of 6.0% from 2019 to reach USD $40.85 Billion by the year 2025. Top-down and bottom-up approaches were used to estimate and validate the size of the Industry and to estimate the size of various other dependent subIndustrys. The overall Industry size was used in the top-down approach to estimate the sizes of other individual subIndustrys (mentioned in the Industry segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research.

Purchase This Report Just For 2990 USD at https://www.globalreportsstore.com/checkout/11719

The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the Industry segment revenues obtained. Various secondary sources such as World Health Organization, US Food and Drug Administration, Centers for Disease Control and Prevention, and European Commission have been used to identify and collect information useful for this extensive commercial study of the biosimilars Industry.

Major market players in Biosimilars Industry are Pfizer, Sandoz, Teva Pharmaceuticals, Amgen, Biocon, Dr. Reddy’s Laboratories, Celltrion, Samsung Biologics, CP Guojian Pharma, Biotech Pharma, Celgen Pharma, Henlius.

Biosimilars Industry Segmentation:

Biosimilars Industry, By Product

  • Recombinant Non-glycosylated Proteins
  • Insulin
  • Recombinant Human Growth Hormone
  • Granulocyte Colony-stimulating Factor
  • Interferons
    • Interferon-Beta
    • Interferon-Alpha
  • Recombinant Glycosylated Proteins
  • Erythropoietin
  • Monoclonal Antibodies
    • Rituximab
    • Infliximab
    • Adalimumab
    • Other Monoclonal Antibodies
  • Follitropin
  • Recombinant Peptides
  • Glucagon
  • Calcitonin

Biosimilars Industry, By Type of Manufacturing

  • In-house Manufacturing
  • Contract Manufacturing

Biosimilars Industry, By Disease

  • Oncology
  • Blood Disorders
  • Chronic Diseases
  • Autoimmune Diseases
  • Growth Hormone Deficiency
  • Infectious Diseases
  • Other Diseases

Ask For Sample at https://www.globalreportsstore.com/request-sample/11719

Get Complete TOC at https://tinyurl.com/y4wxetmk

Contact Us:

Jon

Sales Manager

IND: +91-739-102-4425

sales@globalreportsstore.com